LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
LONA is expected to report earnings to fall 7.55% to -73 cents per share on November 05
Q3'26
Est.
$-0.74
Q2'26
Beat
by $0.32
Q1'26
Missed
by $1.54
Q4'25
Missed
by $18.80
The last earnings report on August 17 showed earnings per share of -80 cents, beating the estimate of -112 cents. With 4.70K shares outstanding, the current market capitalization sits at 72.41M.